China Focus brings together investors, pharma leaders, and biotech & Medtech innovators from China and around the world for an exclusive partnering event designed to inspire, educate and foster cross-border investment and collaboration in leading biopharma innovations. The pharma market in China grew to ~Rmb1,558bn (US$226bn) in 2018, at a CAGR of 10% in 2013-18, becoming the 2nd largest pharma market in the world. As the youngest member of ICH (International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use), China joined with the least experience but holding the promise to bring domestic clinical trials to world standard and open its market. There will be new revenues for innovative therapeutics and more business development opportunities for global players. The current U.S.-China relationship and CFIUS regulations in the U.S. derived interest from some Chinese investors to the European market.

Following the successful China Focus@Europe Vienna in March 2019，we have received increasing interest from Chinese companies to expand business development activities in European countries. In order to better connect Chinese companies and European markets, China Focus comes to Europe again this November, featuring keynote speech, panel discussion, Chinese companies showcase, 1-on-1 meeting, and company presentation (Pitch & Match).